NDC 76420-326
Meloxicam 15 mg tablet
On the label: Asclemed USA, Inc.. It's repackaged: Asclemed USA, Inc. rebottles it from Cipla USA., Inc.'s NDC 69097-159.
Where the pills inside were made
This label doesn't name the factory that makes the drug. Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants Cipla USA., Inc. names for other drugs.
Repackaging site
- Asclemed USA Inc. dba Enovachem, Torrance, CA, United States · repackages it and relabels it
Recalls
- Jan 26, 2022 · Class II · Cardinal Healthcare
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Lots: Batch KA11489 - Mar 15, 2021 · Class II · Cardinal Health Inc.
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Lots: KA03034
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Meloxicam: every company that makes it
- Form
- tablet, oral
- Strength
- 15 mg
- Approval
- ANDA ANDA077929
- On the market since
- Jul 19, 2006
- Package NDCs
76420-326-0076420-326-0176420-326-0576420-326-2076420-326-3076420-326-6076420-326-90- Official label
- DailyMed (National Library of Medicine), updated May 2, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?